ESRX : Analysis & Opinions

  1. Benzinga Market Primer: Monday, July 29: Futures Lower On Chinese ...

    July 29, 2013
    Futures Lower On Chinese FearsU.S. equity futures traded slightly lower in early pre-market trade after Asian shares on fears ...
  2. Encouraging June Sales for Walgreens - Analyst Blog

    July 5, 2013
    Walgreens' sales improve in Jun 2013.
  3. McKesson CEO's $159 Million Pension: Should Shareholders Be Concerned?

    June 27, 2013
    Drug distribution company McKesson (NYSE:MCK) revealed in a June 21 regulatory filing that had CEO John Hammergren retired ...
  4. Walgreens 3Q Earnings: Will it Miss? - Analyst Blog

    June 21, 2013
    Walgreens is set to report third-quarter fiscal 2013 results on Jun 25.
  5. Healthways Agrees with Carondelet - Analyst Blog

    February 11, 2013
    Leading well-being enhancement company Healthways (HWAY) and Carondelet Health Network recently revealed an agreement to ...
  6. All-Front Beat for CVS, Up Y-Y - Analyst Blog

    February 6, 2013
    CVS Caremark (CVS) reported fourth-quarter 2012 EPS of 90 cents, up 11.1% year over year. However, excluding the loss on ...
  7. CVS Caremark Soars to a New High - Analyst Blog

    January 24, 2013
    Shares of CVS Caremark (CVS) reached a new 52-week high of $52.63 on Wednesday, Jan 23, 2013. The stock continues to edge ...
  8. Still Neutral on Walgreens - Analyst Blog

    January 21, 2013
    We reiterate our Neutral recommendation on Walgreens (WAG) following the first quarter fiscal 2013 results. While the company's ...
  9. Steady Flu Supplies from Safeway - Analyst Blog

    January 17, 2013
    In its concerted effort to meet the rising demand for vaccines in the ongoing flu season, Safeway Inc. (SWY) supplied its ...
  10. Walgreens' Analyst Meet Excerpts - Analyst Blog

    January 15, 2013
    Recently, Walgreens (WAG) discussed the current business environment and provided valuable insight into its future operations. ...
  11. Walgreens Discusses Growth Strategy - Analyst Blog

    January 14, 2013
    Recently, Walgreens (WAG) debriefed the investors on its growth strategy for fiscal 2013, while discussing the current business ...
  12. Lackluster Monthly Sales for WAG - Analyst Blog

    January 7, 2013
    Drug retailer Walgreen Co. (WAG) continued to disappoint with its monthly results as it witnessed another dull month, with ...
  13. Cystic Fibrosis Stake for Walgreens (revised) - Analyst Blog

    December 11, 2012
    Walgreen Co. (TRV) has been taking strategic steps to negate the impact of the initial contract loss with Express Scripts ...
  14. Cystic Fibrosis Stake for Walgreen - Analyst Blog

    December 10, 2012
    Walgreen co. (WAG) has been taking strategic steps to negate the impact of the initial contract loss with Express Scripts ...
  15. Express Scripts and More Big Movers in Healthcare on November ...

    November 29, 2012
    On a good day for the market, the Nasdaq is trading up 0.5%, the S&P 500 has moved up 0.5% and the Dow has risen 0.4%. The ...
  16. Mixed 3Q for CVS Caremark - Analyst Blog

    November 6, 2012
    CVS Caremark (CVS) reported third quarter 2012 earnings per share (EPS) of 79 cents, up 21.5% year over year. However, after ...
  17. Express Scripts and Other Big Movers on the Nasdaq on November ...

    November 6, 2012
    The Nasdaq has been relatively flat, the S&P 500 has moved up 0.4% and the Dow has increased 0.6% so far today. Most stocks ...
  18. Novo Nordisk A/S and More Big Movers in Healthcare on November ...

    November 6, 2012
    The Nasdaq remains relatively unchanged, the S&P 500 has climbed 0.4% and the Dow is trading up 0.6% so far today. The healthcare ...
  19. Lower September Sales for Walgreen - Analyst Blog

    October 4, 2012
    Drug retailer Walgreen Co. (WAG) posted dismal sales results for the month of September 2012, recording a decline of 7.8% ...
  20. Still Neutral on AmerisourceBergen - Analyst Blog

    October 3, 2012
    We are maintaining our Neutral recommendation on AmerisourceBergen Corporation (ABC), which carries a Zacks #3 Rank (Hold ...
  21. WAG Buys Cystic Fibrosis Stake - Analyst Blog

    October 3, 2012
    To negate the impact of the initial contract loss with Express Scripts Holding Company (ESRX) as well as to win back former ...
  22. Yet Another Buy for Walgreen - Analyst Blog

    September 19, 2012
    Despite several recent headwinds, Walgreen (WAG) has been successful in maintaining its nonstop shopping spree. Following ...
  23. BioScrip Remains Neutral - Analyst Blog

    August 24, 2012
    We are maintaining our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $8.00. BioScrip reported a ...
  24. Big Movers on the Healthcare Sector Today, Including ESRX

    August 8, 2012
    On a good day for the market, the Nasdaq has climbed 0.1%, the S&P 500 has risen 0.2% and the Dow is up 0.3%. The healthcare ...
  25. Express Scripts Tops, Lifts View - Analyst Blog

    August 8, 2012
    Express Scripts Holding Company's (ESRX) second-quarter 2012 adjusted earnings of 88 cents per share beat the Zacks Consensus ...
  26. Mixed 2Q for CVS, Raises Outlook - Analyst Blog

    August 7, 2012
    CVS Caremark (CVS) reported second quarter 2012 EPS of 75 cents, up 25% year over year. However, after excluding the impact ...
  27. Catalyst Health Acquired by SXC - Analyst Blog

    July 5, 2012
    On Monday, Catalyst Health Solutions Inc. was acquired by rival pharmacy benefits management (PBM) company, SXC Health Solutions ...
  28. Walgreen Hopes That It Can Buy Growth

    June 25, 2012
    Buying Alliance Boots is a major strategic shift for a pharmacy chain struggling to maintain its market relevance
  29. CVS Caremark On A Healthy Upward Path

    May 31, 2012
    CVS Caremark is one of the safer bets in the drug retail space.
  30. ESRX Loss Hurts Walgreen Again - Analyst Blog

    May 8, 2012
    The termination of the Express Scripts (ESRX) contract continues to hurt Walgreen's (WAG) sales, which once again disappointed ...
  31. Strong 1Q for CVS, Guidance Up - Analyst Blog

    May 2, 2012
    Strong 1Q for CVS, Guidance Up - Analyst Blog
  32. CVS Caremark’s Dispensing A Modest Outlook

    February 10, 2012
    Much of CVS Caremark's future growth is already discounted in the share price.
  33. U.S. Stocks: Why America Is Recovering From The Debt Bust Faster ...

    January 24, 2012
    Private debt levels are helping America see a faster recovery from debt than Eurpoe is experiencing.
  34. What Is Walgreen's Next Trick?

    September 30, 2011
    Walgreen is doing okay today, but tomorrow is a much bigger question.
  35. 3 Industries Enjoying Boomer-Fueled Growth

    August 20, 2011
    Big Joe Clark sees baby boomers continuing to spend in the areas of health care, retail, and education. He also cautions ...
  36. Teva And Mylan Show Some Value Remains In Generics

    August 4, 2011
    These two generics companies seem to be heading in opposite directions, but the values are similar.
  37. Will Patience Pay For Walgreen Shareholders?

    March 23, 2011
    The drug retailing business is getting tougher, but Walgreen is a proven winner.
  38. Medco Looks To Stay In The Pink

    February 24, 2011
    Medco continues to deliver the goods, while contract worries hang over the stock.
  39. PBMs: Making The Most Of Generics

    February 3, 2011
    PBMs stand to benefit from the generic introduction of blockbuster drugs. Has the market fully discounted the opportunity?
  40. CVS Caremark A Show-Me Stock

    November 8, 2010
    If CVS Caremark delivers on its promise to grow free cash flow over the coming five years, investors will finally see significant ...
  41. Gains In Healthcare IT

    October 13, 2010
    By adopting healthcare information technology, hospitals and clinics will be able to achieve cost savings as well as new ...
  42. Medco A Top Pharmacy Stock Pick

    March 25, 2009
    Medco looks to be the healthiest company among its peers, but is now the time to buy?
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center